Remsima News - Latest Updates & Headlines
Celltrion targets $3.46 bn in sales this year on biosimilars
Seoul, March 18: Celltrion, a major South Korean biopharmaceutical firm, on Tuesday said it aims to achieve 5 trillion won ($3.46 billion) in sales this year, helped by an expanded biosimilar lineup.